Furiex Pharmaceuticals, Inc. (FURX) Reports a Q2 loss
Tweet Send to a Friend
Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) reported Q2 EPS of ($2.09), $1.62 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
